Page 133 - Technology Platform News Today

Melbourne's Bourne Digital has been swallowed up by global professional services giant Accenture, for an undisclosed sum.

SoFi Technologies, Inc. (NASDAQ:SOFI – Get Rating) was the recipient of unusually large options trading activity on Tuesday. Stock investors bought 295,229 call options on the company. This represents an increase of approximately 102% compared to the average volume of 146,249 call options. SoFi Technologies Stock Up 11.5 % Shares of SoFi Technologies stock traded […]

Icapital Wealth LLC decreased its stake in SoFi Technologies, Inc. (NASDAQ:SOFI – Get Rating) by 87.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,700 shares of the company’s stock after selling 75,900 shares during the period. Icapital Wealth LLC’s holdings […]

Shares of SoFi Technologies, Inc. (NASDAQ:SOFI – Get Rating) saw strong trading volume on Wednesday . 20,961,243 shares were traded during trading, a decline of 45% from the previous session’s volume of 38,233,887 shares.The stock last traded at $6.74 and had previously closed at $6.03. Wall Street Analyst Weigh In A number of equities research […]

REGENXBIO Inc. (NASDAQ:RGNX – Get Rating)’s share price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $17.02 and last traded at $17.23, with a volume of 897356 shares. The stock had previously closed at $17.50. Analyst Ratings Changes Several research analysts have weighed in on RGNX […]

SoFi Technologies, Inc. , the digital personal finance company, today announced plans to host its 2023 annual meeting of stockholders on Wednesday, June 14, 2023, at 7:00 a.m., Pacific Time . The... | June 7, 2023

For SAP customers, SAP S/4HANA represents more than a technical upgrade; it’s a major functional change.

SAP Business AI, the Green Ledger, and business-ready innovations across the portfolio underscore SAP’s ability to help customers solve their most pressing

Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the nine ratings firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target […]

Osiris Therapeutics (OTCMKTS:OSIR – Get Rating) and REGENXBIO (NASDAQ:RGNX – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Valuation and Earnings This table compares Osiris Therapeutics and REGENXBIO’s […]